Shijiazhuang Yiling Pharmaceutical: Report of the Audit Committee of the Board of Directors of Eling Pharmaceutical on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties

SZSI · Apr 27

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

以岭药业：以岭药业董事会审计委员会对会计师事务所2023年度履职情况评估及履行监督职责情况的报告

Shijiazhuang Yiling Pharmaceutical: Report of the Audit Committee of the Board of Directors of Eling Pharmaceutical on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties

Risk Disclaimer

Statement